WASHINGTON — Citing confidentiality agreements tied to the experimental retatrutide regimen, White House counsel confirmed Monday that President Trump's metabolic data is now legally protected intellectual property.

Officials stated disclosing his weight would constitute corporate espionage. The FDA noted it cannot regulate the unseen. "His physiology is under NDA until Q3 earnings," said Press Secretary Karoline Leavitt.